Opioids

FDA: Opioid Analgesic REMS Expanded to Include Immediate-Release Products

FDA: Opioid Analgesic REMS Expanded to Include Immediate-Release Products

By

As part of the REMS program, drug companies with approved opioid analgesics must make training available to prescribers and provide unrestricted grants to accredited continuing education providers for the development of education courses.

Opioids Often Prescribed in the Absence of Pain Diagnosis

Opioids Often Prescribed in the Absence of Pain Diagnosis

Many outpatient opioid prescriptions have no documented medical indication.

Oxycontin's Maker Now Selling Drug to Curb Opioid Addiction

Oxycontin's Maker Now Selling Drug to Curb Opioid Addiction

Purdue Pharma, the maker of Oxycontin who some have blamed for the epidemic of opioid painkiller addictions, has patented a medicine aimed at curbing those disorders.

With New Persistent Opioid Use, Most Early Scripts From Surgeons

With New Persistent Opioid Use, Most Early Scripts From Surgeons

Among surgical patients who develop new persistent opioid use, surgeons provide the majority of opioid prescriptions in the first few months after surgery.

Opioid Maker to Pay for Overdose Antidote Development

Opioid Maker to Pay for Overdose Antidote Development

A $3.4 million grant to help a non-profit company develop a less expensive opioid overdose antidote was announced by Purdue Pharma, which makes the opioid painkiller OxyContin.

Pregabalin may increase the risk of death when coprescribed with opioids

Patients coprescribed opioids and pregabalin had significantly increased odds of opioid-related death compared to opioid prescription alone.

FDA Outlines Plan for New Analgesic Guidance to Combat Opioid Crisis

FDA Outlines Plan for New Analgesic Guidance to Combat Opioid Crisis

By

The new plan will break out the current guidance into 4 separate guidances.

US Opioid Use Not Declining, Despite Focus on Abuse

US Opioid Use Not Declining, Despite Focus on Abuse

Rates of opioid use in the United States do not appear to be declining.

FDA Warning Letters Target Illegal Online Sales of Opioids

FDA Warning Letters Target Illegal Online Sales of Opioids

Four more online networks that operate 21 websites illegally selling potentially dangerous, unapproved, and misbranded versions of opioid pain medications have been told to immediately stop their sales.

Odds of Death Up With Exposure to Pregabalin, Opioids

Odds of Death Up With Exposure to Pregabalin, Opioids

Concomitant exposure to pregabalin and opioids is associated with increased odds of opioid-related death.

DEA Proposal Will Significantly Cut Opioid Manufacturing in 2019

DEA Proposal Will Significantly Cut Opioid Manufacturing in 2019

By

Last year, the DEA proposed a 20% reduction in the manufacturing of controlled substances for 2018 compared to 2017.

Outpatient Opioid Prescriptions for Children Often Filled

Outpatient Opioid Prescriptions for Children Often Filled

Children often fill outpatient opioid prescriptions, with the most common indication for dental procedures.

NIH Initiative Aims to Address Opioid Misuse Over Long Term

NIH Initiative Aims to Address Opioid Misuse Over Long Term

A novel, innovative initiative is being developed to help end addiction over the long term.

Meds for Opioid Use Disorder May Reduce Mortality in OD Survivors

Meds for Opioid Use Disorder May Reduce Mortality in OD Survivors

Use of medications for opioid use disorder is associated with a reduction in all-cause and opioid-related mortality after opioid overdose.

Illicit Opioid Trade Up With Restrictions on Hydrocodone

Illicit Opioid Trade Up With Restrictions on Hydrocodone

The US Drug Enforcement Administration's 2014 ruling to reschedule hydrocodone combination products coincided with an increase in illicit trading of opioids through online illicit markets.

FDA Warns Websites Marketing Unapproved Opioids

FDA Warns Websites Marketing Unapproved Opioids

Nine online networks have been warned that they must stop illegally marketing potentially dangerous, and misbranded versions of opioid medications.

FDA: Opioid Antidote Naloxone Recalled

FDA: Opioid Antidote Naloxone Recalled

A recall of the opioid overdose antidote Naloxone was announced Monday.

NDA for First-of-Its-Kind Opioid Analgesic Submitted to FDA

NDA for First-of-Its-Kind Opioid Analgesic Submitted to FDA

By

A NDA has been submitted for NKTR-181, an opioid analgesic molecule designed to provide pain relief with fewer CNS-mediated side effects.

Study IDs Unintended Consequence of Prescription Drug Monitoring Programs

Study IDs Unintended Consequence of Prescription Drug Monitoring Programs

By

Evidence on whether the implementation of prescription drug monitory programs increases or decreases opioid-related overdoses was found to be "largely insufficient".

Suicidal Behavior Increased With Opioids, Psychotropic Medication Misuse in Epilepsy

Suicidal Behavior Increased With Opioids, Psychotropic Medication Misuse in Epilepsy

By

Investigators conducted a population-based study to assess risk and cause of unnatural mortality in individuals with epilepsy.

Education, Depression, Pain Associated With Opioid Misuse

Education, Depression, Pain Associated With Opioid Misuse

Higher education, illicit drug use, depression, and pain interference with normal work are significantly associated with opioid misuse.

Fentanyl Use Associated With Amnesia: Case Report

Fentanyl Use Associated With Amnesia: Case Report

Another case of unusual amnestic syndrome that includes bilateral hippocampal lesions on MRI has been described.

Opioid Disposal Improved With Educational Brochure

Opioid Disposal Improved With Educational Brochure

Disposal of unused opioids after surgery is improved with an educational brochure.

Opioid Prescriptions Up With Low Socioeconomic Level

Opioid Prescriptions Up With Low Socioeconomic Level

The authors examined the demographic and geographic variation and the correlation between the local economic environment and measures of individual opioid prescriptions.

Intranasal, Intramuscular Naloxone Equally As Effective for Opioid Overdose

Intranasal, Intramuscular Naloxone Equally As Effective for Opioid Overdose

Higher-concentration intranasal naloxone has similar efficacy to that of intramuscular naloxone given at the same dose for reversal of opioid overdose.

Baby Boomers at High Risk for Death From Prescription Opioid Overdose

Baby Boomers at High Risk for Death From Prescription Opioid Overdose

There is a significantly increased risk of prescription opioid deaths for those born between 1947 and 1964.

Immediate Access to Opioid Agonists Reduces Associated Health Care Costs

Immediate Access to Opioid Agonists Reduces Associated Health Care Costs

There may be more health benefits at a lower cost with immediate access to opioid agonist treatment for patients with opioid use disorder.

Gabapentin, Opioid Combo May Increase Risk of Opioid-Related Death

Gabapentin, Opioid Combo May Increase Risk of Opioid-Related Death

By

There is a higher risk for opioid-related death in patients taking concomitant prescription opioids and gabapentin.

Medicare Boosted Restrictions on Opioids From 2006-2015

Medicare Boosted Restrictions on Opioids From 2006-2015

Medicare Part D formularies increasingly used quantity limits and prior authorization in order to reduce dosing of prescription opioids.

What's the Optimal Length of Post-Op Opioid  Tx?

What's the Optimal Length of Post-Op Opioid Tx?

After surgical procedures, the optimal length of opioid prescription lies between the observed median prescription length and the early nadir.

Sign Up for Free e-newsletters



CME Focus